US2013143949A1PendingUtilityA1
G-CSF Transferrin Fusion Proteins
Est. expiryOct 10, 2023(expired)· nominal 20-yr term from priority
C07K 19/00C07K 2319/10A61P 31/00A61K 47/644A61P 7/06C07K 14/79C07K 2319/74C07K 14/535A61K 38/193
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A polypeptide comprising a G-CSF domain operably linked to a Tf domain, wherein the ability of the polypeptide to be transported into a cell expressing a TfR gene or the ability of the polypeptide to be transported across a cell expressing a TfR gene via transcytosis is higher than that of the G-CSF domain alone.
Claims
exact text as granted — not AI-modified1 - 11 . (canceled)
12 . A nucleic acid comprising a DNA sequence encoding a recombinant polypeptide comprising a granulocyte colony stimulating factor (G-CSF) domain operably linked to a transferring (Tf) domain, wherein the ability of the polypeptide to be transported into a cell expressing a transferring receptor (TfR) gene or the ability of the polypeptide to be transported across a cell expressing a TfR gene via transcytosis is higher than that of the G-CSF domain alone.
13 . A cell comprising the nucleic acid of claim 12 .
14 . (canceled)
15 . (canceled)
16 . A composition comprising a pharmaceutically acceptable carrier and the nucleic acid of claim 12 .
17 . A method of producing a polypeptide, comprising cultivating the cell of claim 13 under conditions that allow expression of the polypeptide.
18 . The method of claim 17 , further comprising collecting the polynucleotide.
19 - 30 . (canceled)
31 . The polypeptide of claim 12 , wherein the G-CSF domain and the Tf domain are linked through covalent bonding.
32 . The polypeptide of claim 31 , wherein the G-CSF domain and the Tf domain are linked through a disulfide bond.
33 . The polypeptide of claim 12 , wherein the G-CSF domain is linked to the Tf domain through a linker.
34 . The polypeptide of claim 12 , wherein the G-CSF domain is linked to the Tf domain through a Leu-Glu linker.
35 . The polypeptide of claim 12 , further comprising a secretion signal at the N-terminus.
36 . The polypeptide of claim 12 , wherein the order of the G-CSF domain and the Tf domain is from the N-terminus to the C-terminus.
37 . The method of producing a polypeptide according to claim 17 , comprising contacting the polypeptide with iron such that the recombinant polypeptide is loaded with iron.
38 . The cell according to claim 13 , further comprising iron.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.